Advancing cell-based cancer immunotherapy through stem cell engineering
Cell Stem Cell · 2023-05 · 30 (5) · 592-610
DOI: 10.1016/j.stem.2023.02.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Stem Cell, 2023-05. Verfasst von Yan-Ruide Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, California Institute for Regenerative Medicine, Concern Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Mork Family Department of Chemical Engineering and Materials Science, University of Souther…
- Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA; Department of Pharmacology and Pharmaceutical Sciences, University of Southern Califor…
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of…
Förderung
- NCI NIH HHS
- California Institute for Regenerative Medicine
- Concern Foundation
- STOP CANCER
- University of California, Los Angeles
- National Institutes of Health
- The Rose Hills Foundation
- USC
Zitieren
APA
Li, Y. R., Dunn, Z. S., Yu, Y., Li, M., Wang, P., & Yang, L. (2023). Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell, 30(5), 592-610. https://doi.org/10.1016/j.stem.2023.02.009
Vancouver
Li YR, Dunn ZS, Yu Y, Li M, Wang P, Yang L. Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell. 2023;30(5):592-610. doi:10.1016/j.stem.2023.02.009
BibTeX
@article{Li2023,
author = {Li, Yan-Ruide and Dunn, Zachary Spencer and Yu, Yanqi and Li, Miao and Wang, Pin and Yang, Lili},
title = {Advancing cell-based cancer immunotherapy through stem cell engineering},
journal = {Cell Stem Cell},
year = {2023},
volume = {30},
number = {5},
pages = {592--610},
doi = {10.1016/j.stem.2023.02.009}
}
EUVIMED